© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Coya Therapeutics, Inc. (COYA) shows an Average True Range (ATR) of 0.35 and an Enterprise Value of 89.68M. Its average trading volume over the past 3 months is 201.41K, indicating liquidity. These fundamental metrics provide insight into COYA's underlying financial health and market activity.
Coya Therapeutics, Inc. (COYA) technical indicators as of December 22, 2025: the SMA 20 is -8.68%, SMA 50 at -10.62%, and SMA 200 at -9.34%. The RSI 14 value is 39.05, suggesting its current momentum. These technical analysis signals help assess COYA's price trends and potential future movements.
Coya Therapeutics, Inc. (COYA) stock performance overview as of December 22, 2025: The 52-week high is $8.29 (currently -33.78% below), and the 52-week low is $4.65 (currently 18.06% above). Over the past year, COYA's performance is -6.79%, compared to the S&P 500's 12.87% change.
According to market data, Coya Therapeutics, Inc. (COYA) stock's recent performance metrics show that over the last month, COYA is -10.88%, with a Year-to-Date (YTD) performance of -4.19%. Over the past year, the stock has seen a -6.79% change. These figures summarize COYA's price movements across various periods, reflecting its historical returns.
According to current financial data, COYA stock's P/E (TTM) ratio is -0.02, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for COYA, including P/S (215.42), P/B (0.00), and P/FCF (-0.01), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.